Biohaven Ltd.BHVN

$13.57-0.05 (-0.37%)

NYSEHealthcare24:00 UTC

Company snapshot

Market Cap

$2B

Mid-cap

+545%

2022 — today

10-Year Price

+57%

2022 — today

52-Week Range

$7.79$18.11

Current $13.57· 56%

Biohaven Ltd. operates as a biopharmaceutical firm actively engaged in clinical trials. Its primary objective is to advance innovative treatments for disorders affecting the nervous and immune systems, with the potential to transform current medical interventions.

Valuation in context

P/E ratio

-2.4

N/A

Not meaningful — company is unprofitable

P/B ratio

15.5

Near historic high

Near historic highs — last 10 years

FCF Yield

-29.7%

Around average

Around the 10-year average

Free · No credit card needed

Get alerted when BHVN is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.